Paper8098014
Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma.
Foulkes WD and 4 others. Int J Cancer, 1993. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Papers, record 8098014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8098014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chromosome Aberrations | Major topic |
| Chromosomes, Human, Pair 17 | Major topic |
| Ovarian Neoplasms | Major topic |
| Chromosome Disorders | |
| Chromosome Mapping | |
| Female | |
| Heterozygote | |
| Humans | |
| Polymorphism, Restriction Fragment Length | |
| Prohibitins | |
| Repetitive Sequences, Nucleic Acid |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38286829 | Aneuploidy and complex genomic rearrangements in cancer evolution. | Nat Cancer | 2024 | https://conductscience.org/library/papers/38286829 | PubMed |
| 23552840 | Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity. | Oncogenesis | 2012 | https://conductscience.org/library/papers/23552840 | PubMed |
| 23029043 | The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome. | PLoS One | 2012 | https://conductscience.org/library/papers/23029043 | PubMed |
| 18474296 | Genomic structure of chromosome 17 deletions in BRCA1-associated ovarian cancers. | Cancer Genet Cytogenet | 2008 | https://conductscience.org/library/papers/18474296 | PubMed |
| 12629520 | Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines. | Oncogene | 2003 | https://conductscience.org/library/papers/12629520 | PubMed |
| 10723138 | Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers. | Oncogene | 2000 | https://conductscience.org/library/papers/10723138 | PubMed |
| 10597224 | 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification. | Oncogene | 1999 | https://conductscience.org/library/papers/10597224 | PubMed |
| 9292705 | Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findings. | J Cancer Res Clin Oncol | 1997 | https://conductscience.org/library/papers/9292705 | PubMed |
| 8932340 | Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8932340 | PubMed |
| 8826850 | High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8826850 | PubMed |
| 8679443 | Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8679443 | PubMed |
| 8241896 | Tumour suppressor genes in ovarian cancer. | BMJ | 1993 | https://conductscience.org/library/papers/8241896 | PubMed |
| 7947096 | Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12. | Br J Cancer | 1994 | https://conductscience.org/library/papers/7947096 | PubMed |
| 7942844 | A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. | Am J Hum Genet | 1994 | https://conductscience.org/library/papers/7942844 | PubMed |
| 7852189 | Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary. | Jpn J Cancer Res | 1994 | https://conductscience.org/library/papers/7852189 | PubMed |
| 7734326 | Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7734326 | PubMed |
| 7669555 | The genetic analysis of ovarian cancer. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7669555 | PubMed |
| 7547235 | MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7547235 | PubMed |
| 7490308 | Molecular genetics of familial breast-ovarian cancer. | J Clin Pathol | 1995 | https://conductscience.org/library/papers/7490308 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| HSD17B2 | 3294 | PubTator's text mining | https://conductscience.org/library/genes/3294 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8098014
GET https://conductscience.org/api/papers/v1/8098014/authors